GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Innovation Pharmaceuticals IPIX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Innovation Pharmaceuticals — daily IPIX Delayed
Market value
$252,884
Last close × shares
Volume
657.1k
Shares, 9 Nov 2026

About Innovation Pharmaceuticals

Its shares trade under the ticker IPIX. It has been listed since 2 April 2007. In the fiscal year to 30 June 2023, it reported revenue of $18,000 and a net loss of $3.2m. At that date it held total assets of $7.5m and shareholders' equity of $2.0m.

Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company. The company is headquartered in Wakefield, Massachusetts. The company went IPO on 2007-04-02. The firm is engaged in developing therapies with oncology, dermatology and antimicrobial applications. The firm owns the rights to various drug compounds, including Kevetrin (thioureidobutyronitrile), which is its anti-cancer compound; Prurisol (KM-133), which is in development for psoriasis, and Brilacidin, which is its drug in a class of compounds known as defensin-mimetics. The firm's clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Prurisol for the treatment of psoriasis, and Brilacidin for treatments of skin infections, prevention of oral mucositis complicating chemoradiation treatment for cancer, and ulcerative proctitis. The firm focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics and inflammatory disease.

Figures and description from our data supplier, not checked against the company's own report.

More about Innovation Pharmaceuticals →

Latest on Innovation Pharmaceuticals

Our reporting

We have not reported on Innovation Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Innovation Pharmaceuticals's ticker?

Innovation Pharmaceuticals trades as IPIX on its US listing, under ISIN US45782D1000.

What was Innovation Pharmaceuticals's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.